ADVANCED PEPTIDE THERAPY
Peptides are naturally occurring amino acids that are utilized as therapy for a variety of conditions. Many of the body's naturally occurring processes utilize peptides for cell signaling and to improve growth hormone secretion, wound healing, reduce inflammation, enhance energy, promote weight loss, and improve skin tone.
Peptide therapy is an adjunct and works in synergy with testosterone replacement therapy to improve treatment results and benefits.
HOW DO PEPTIDES WORK
Growth Hormone (GH), also known as somatropin, is a 191 amino acid protein that has many roles in human physiology, principal among them are skeletal muscle growth, lipolysis, and regulation of lean body mass.
Many peptide therapies induce growth hormone secretion directly from the pituitary gland or act as a growth hormone-releasing secretagogue (somatocrinin) in the hypothalamus. The gravitation toward peptide therapy to improve natural growth hormone levels compared to exogenous recombinant growth hormone has gained much attraction given their safety and efficacy to provide results.
THE PEPTIDES BELOW MAY BE UTILIZED TO IMPROVE LEAN BODY MASS, PHYSIQUE, MUSCLE GROWTH, SKIN QUALITY, FAT LOSS, AND SLEEP QUALITY.
NAD +
NAD plays a vital role in many of the body's natural processes, such as enhancing cellular energy, protecting against free radicals and cellular stress, improving ATP production, and protecting DNA degradation. Restoring NAD levels in men has been the attraction of much research as a potential to reverse and or slow the aging process and improve quality of life measures that include:
+ Enhancing energy and performance
+ Boosting Immunity
+ Assisting with weight loss
+ Improving vascular health
+ Reduce Inflammation
IBUTAMOREN
MK 677
Ibutamoren MK 677 is a novel orally active growth hormone secretagogue. Ibutamoren MK 677 has been extensively studied in humans and has profound effects on increasing natural growth hormone (GH) secretion and IGF-1 levels. In two randomized placebo-controlled studies, Ibutamoren MK 677 was found to increase fat-free mass (FFM) and improve REM sleep. The fat loss was accompanied by an increase in lean muscle mass and thigh muscle mass in patients taking Ibutamoren MK 677.
+ MK 677 formulated in several dosages
+ Increase appetite expected initially
SERMORELIN
GHRH 1-29
Sermorelin is a GHRH analog used to treat and diagnose GH deficiency. Sermorelin is a very potent peptide that stimulates increases in IGF-1 and GH levels in as little as two weeks after use.
Sermorelin is one of the most well-studied GHRH peptides in its class. It has gained much attention for its ability to improve pituitary health and natural growth hormone secretion in a safe and effective manner.
+ Improves sleep quality and recovery
+ Promotes lean body mass and weight loss
BREMALNOTIDE
PT 141
Bremelanotide also known as PT 141 is a peptide approved for treating sexual dysfunction, primarily loss of sexual desire, in men. PT 141 is a nasal spray that is taken just before intercourse to enhance arousal, libido and erectile response to stimuli. PT 141 is a valuable adjunct to treat men who want to 1) improve sexual desire, 2) improve sexual satisfaction during activity 3) treat erectile dysfunction or 4) fail to respond well to Viagra or Cialis.
+ Enhances libido
+ Can improve response to Viagra ®️ or Cialis ®️
HEXARELIN
Hexarelin is a potent growth hormone-releasing peptide that can be administered through different methods such as orally, nasally, or via subcutaneous injection. Hexarelin has shown improved efficacy in raising IGF-1 levels compared to GHRH and GHRP-6. Studies have shown that oral administration of hexarelin significantly increases IGF-1 levels in men and may have cardioprotective effects.
+ Oral & Subcutaneous injection available
+ 1mg | 3mg Capsules
+ 6mg Vial (Lyo)
TESAMORELIN
Tesamorelin (Egrifta Depot ®) is a stable Growth Hormone Releasing Hormone (GHRH) that is given to treat the accumulation of body fat. Initially approved by the FDA in 2010, Tesamorelin is an effective peptide to reduce lipodystrophy over a course of 26-52 weeks of treatment. It has a molecular structure that promotes its stability in the body over native GHRH.